Gavi COVAX AMC 2021 Investment Opportunity Launch Event
One World Protected
The Gavi COVAX AMC 2021 Investment Opportunity Launch Event
15 April 2021 | 14:00 CET
-
Press release: Global leaders rally to accelerate access to COVID-19 vaccines for lower-income countries
Video stories
About
On 15 April, Gavi and the United States government brought together world leaders, the private sector, civil society and key technical partners to galvanise resources and commitment to the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC).
The One World Protected event launched the Investment Opportunity for the Gavi COVAX AMC, outlining the urgent need for its continued support and paving the way for a funding Summit in June.
Hosts
|
|
José Manuel Barroso |
|
|
|
Antony Blinken |
|
|
|
Gloria Steele |
|
Key figures
>143
million
pandemic-induced global new poor in 2021.
US$ 9
trillion
potential loss to the global economy if COVID-19 vaccines aren’t globally distributed.
1.8
billion
doses of COVID-19 vaccine could be reserved through the Gavi COVAX AMC in 2021.
92
lower-income economies
stand to benefit from COVID-19 vaccines provided through the Gavi COVAX AMC.
≥ US$ 2
billion
is required by June 2021 to fully fund the Gavi COVAX AMC.
The Gavi COVAX Advance Market Commitment (AMC) is an innovative financial mechanism that ensures the world’s poorest countries will get access to COVID-19 vaccines, regardless of their ability to pay.
United States support for Gavi
In addition to committing US$ 4 billion over 2021 and 2022 to support Gavi’s COVID-19 related work, the U.S. is a long-standing supporter of Gavi. It was one of the Alliance’s original six donors and has contributed more than US$ 2.7 billion to our core work since 2000.
U.S. global health assistance has emphasised ending preventable child deaths through high-impact, low-cost interventions, and provision of vaccines and immunisations through Gavi is an important component of these efforts. Moreover, the United States continues to be a key partner to Gavi by coordinating programmatic objectives to ensure greater efficiency and impact on the ground.
Timeline of U.S. support for Gavi
- 2000: One of the original six founding donors of Gavi
- 2011: Pledges US$ 450 million at Gavi’s first replenishment
- 2015: Pledges US$ 1 billion to Gavi for 2015-2018 period
- 2017: Announces US$ 20 million to support Gavi’s Ebola vaccine stockpile
- 2020: Pledges US$ 1.16 billion to Gavi for the period 2020-2023
- 2020: Provides US$ 4 billion for COVID-19 vaccine procurement and delivery, becoming Gavi’s largest donor
- 2021: Hosts the One World Protected launch meeting (virtual event)
Latest COVAX AMC news
We can stop the cycle of new variants continuing indefinitely with a pandemic vaccine pool
Without it we could face further delays in the global rollout and risk the gulf between the vaccine haves and have nots widening.
COVAX and the other international organizations committed to vaccine equity cannot end the COVID-19 pandemic without the continued support of governments, industry, and civil society. By working together, the world has a chance to tame the…
Vaccination started off slow, but has steadily increased over 2021 thanks to public health messaging and vaccine deliveries.
All around the world, COVAX deliveries are helping to protect frontline health workers, reach nomadic communities, reunite families and allow schools to reopen. Since deliveries began in March, #VaccinesWork has been publishing snapshots that…
How the public came together to support COVID-19 vaccines for the world’s most vulnerable
People around the world have demonstrated global solidarity by donating to the COVAX Facility, providing vaccines to those who would otherwise have no access.
